Emergent BioSolutions Reports Second Quarter 2026 Financial Results
Go back to Emergent BioSolutions Reports Second Quarter 2026 Financial Results| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 6.76 +0.21 (3.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.55 | 52 Week High | $44.38 | |||
| Open | $6.61 | 52 Week Low | $24.47 | |||
| Day High | $6.89 | P/E | 338.00 | |||
| Day Low | $6.54 | EPS | $0.02 | |||
| Volume | 1,144,102 | |||||

